IL1B and inflammatory bowel disease: Several studies have shown that the overexpression of proinflammatory cytokines, such as tumour necrosis factor α (TNF-α) and interleukin (IL)-1β, leads to the activation of NF-κB contributing to the etiopathogenesis of IBD through impairment of intestinal barrier function.